Roche – Innovation in Oncology & Biotech

Roche

Country: Switzerland

F. Hoffmann-La Roche AG (Roche) is a Swiss pharmaceutical company headquartered in Basel, founded in 1896 by Fritz Hoffmann-La Roche. Its shares trade on the SIX Swiss Exchange as part of the SMI index; slightly more than half of the voting shares are held by descendants of the Hoffmann and Oeri families.

Roche has two divisions, Pharmaceuticals and Diagnostics. The group includes the US biotech company Genentech, wholly owned by Roche since 2009, and Japan's Chugai, in which Roche holds a controlling stake. Its pharmaceutical business focuses on oncology, immunology, neuroscience, ophthalmology and infectious diseases.

Roche is one of the pioneers of biological cancer therapy, with monoclonal antibodies such as Avastin (bevacizumab), Herceptin (trastuzumab) and MabThera (rituximab). In Turkey, Avastin is sold under the name Altuzan. Zelboraf (vemurafenib) is a BRAF kinase inhibitor approved in 2011 for metastatic melanoma with a BRAF V600 mutation. Vesanoid (tretinoin) is a vitamin A derivative used in acute promyelocytic leukaemia; in a number of countries the rights to it have passed to the German company Cheplapharm.

Unifarm carries Roche's oncology medicines Altuzan 400 (bevacizumab), Zelboraf (vemurafenib) and Vesanoid (tretinoin).

Official manufacturer website
Roche

List of medicines by manufacturer Roche

-9%
Altuzan 400
View
Roche
400 mg 1 vial
24404₴ 26895₴
--31%
Zelboraf
View
Roche
240 mg 56 tablets
23797₴
-1%
Vesanoid
View
Roche
10 mg 100 capsules
24850₴ 25032₴
✅ All products loaded (3)

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00